youtube_live
Q3 2026 earnings • released • EPS miss -119.27% • Revenue miss -16.77%
See resultschevron_right
IAM:NASDAQ
Iambic Therapeutics, Inc.
$13.19
arrow_downward
-7.50%(-1.07) 1D
Nov 20, 11:08:11 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IAM...
Open
$14.00
High
$14.00
Low
$12.88
Mkt. cap
625.22M
Avg. vol.
635.48K
Volume
74.04K
52-wk high
$25.00
52-wk low
$9.60
EPS
-$1.99
Shares outstanding
6.81M
No. of employees
171
Open
$14.00
High
$14.00
Low
$12.88
Mkt. cap
625.22M
Avg. vol.
635.48K
Volume
74.04K
52-wk high
$25.00
52-wk low
$9.60
EPS
-$1.99
Shares outstanding
6.81M
No. of employees
171
News stories
From web sources and news partners
TradingView
·
19 hours ago
Iambic Therapeutics 3Q 2026: Revenue $11.35M, EPS ($8.52) — 10-Q Summary
About Iambic Therapeutics, Inc.